Photo from archive.org
While recent cardiovascular safety trials (CVST) concerning newer diabetes medications included mostly white participants, results are being generalized to all races in recent guidelines. This raises a controversial question regarding… Click to show full abstract
While recent cardiovascular safety trials (CVST) concerning newer diabetes medications included mostly white participants, results are being generalized to all races in recent guidelines. This raises a controversial question regarding the appropriateness of applying CVST data to black patients with type 2 diabetes.
Keywords:
black patients;
patients type;
glp 1ras;
1ras sglt;
sglt 2is;
type diabetes
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!